ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 133 filers reported holding ARCUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $374 | -49.0% | 20,856 | -42.2% | 0.00% | 0.0% |
Q2 2023 | $733 | -18.7% | 36,112 | -27.0% | 0.00% | 0.0% |
Q1 2023 | $902 | -16.6% | 49,459 | -5.4% | 0.00% | 0.0% |
Q4 2022 | $1,081 | -99.9% | 52,277 | +6.8% | 0.00% | -50.0% |
Q3 2022 | $1,280,000 | +9.6% | 48,929 | +6.2% | 0.00% | 0.0% |
Q2 2022 | $1,168,000 | -12.0% | 46,076 | +9.6% | 0.00% | +100.0% |
Q1 2022 | $1,327,000 | +0.4% | 42,045 | +28.7% | 0.00% | 0.0% |
Q4 2021 | $1,322,000 | +15.8% | 32,670 | -0.3% | 0.00% | 0.0% |
Q3 2021 | $1,142,000 | +7.8% | 32,755 | -15.1% | 0.00% | 0.0% |
Q2 2021 | $1,059,000 | -1.3% | 38,559 | +0.9% | 0.00% | 0.0% |
Q1 2021 | $1,073,000 | +8.2% | 38,200 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $992,000 | +97.6% | 38,200 | +30.4% | 0.00% | 0.0% |
Q3 2020 | $502,000 | -30.8% | 29,300 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $725,000 | +78.1% | 29,300 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $407,000 | +37.5% | 29,300 | 0.0% | 0.00% | – |
Q4 2019 | $296,000 | +4.2% | 29,300 | -6.1% | 0.00% | – |
Q3 2019 | $284,000 | +14.5% | 31,200 | 0.0% | 0.00% | – |
Q2 2019 | $248,000 | -36.4% | 31,200 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $390,000 | +473.5% | 31,200 | +395.2% | 0.00% | – |
Q4 2018 | $68,000 | -22.7% | 6,300 | 0.0% | 0.00% | – |
Q3 2018 | $88,000 | +14.3% | 6,300 | 0.0% | 0.00% | – |
Q2 2018 | $77,000 | – | 6,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |